{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:36:41Z","timestamp":1759412201316},"reference-count":19,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T00:00:00Z","timestamp":1506643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.vaccine.2017.09.049","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T10:15:17Z","timestamp":1506593717000},"page":"6154-6159","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Value of an in-depth analysis of unpublished data on the safety of influenza vaccines in pregnant women"],"prefix":"10.1016","volume":"35","author":[{"given":"Neal A.","family":"Halsey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Proveaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.09.049_b0005","unstructured":"Meeting of the Strategic Advisory Group of Experts on immunization, November 2013 \u2013 conclusions and recommendations. Wkly Epidemiol Rec 2014;89(1):1\u201320."},{"issue":"Suppl. 5","key":"10.1016\/j.vaccine.2017.09.049_b0010","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1016\/j.vaccine.2015.10.080","article-title":"The safety of influenza vaccines in children: an institute for vaccine safety white paper","volume":"33","author":"Halsey","year":"2015","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2017.09.049_b0015","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1080\/21645515.2016.1222341","article-title":"The safety of maternal immunization","volume":"12","author":"Regan","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"10.1016\/j.vaccine.2017.09.049_b0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety information from the Vaccine Adverse Event Reporting System","volume":"23","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"48","key":"10.1016\/j.vaccine.2017.09.049_b0025","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1016\/j.vaccine.2014.09.018","article-title":"Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013","volume":"32","author":"Haber","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2017.09.049_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.06.047","article-title":"Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System","volume":"205","author":"Moro","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.09.049_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.08.050","article-title":"Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009","volume":"204","author":"Moro","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.vaccine.2017.09.049_b0040","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1586\/erv.12.72","article-title":"Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy","volume":"11","author":"Moro","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.09.049_b0045","first-page":"1","article-title":"Surveillance systems and methods for monitoring the post-marketing safety of influenza vaccines at the Centers for Disease Control and Prevention","author":"Moro","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.vaccine.2017.09.049_b0050","unstructured":"Moro PL, Lewis P, Cragan J, Tepper N. Safety of Seasonal Influenza Vaccines in Pregnancy in the Vaccine Adverse Event Reporting System, 2010 \u2013 2014. 31st International Conference on Pharmacoepidemiology, August 23-26, 2015, Boston, MA."},{"issue":"2","key":"10.1016\/j.vaccine.2017.09.049_b0055","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s40264-016-0482-1","article-title":"Surveillance of adverse events after seasonal influenza vaccination in pregnant women and their infants in the vaccine adverse event reporting system, July 2010-May 2016","volume":"40","author":"Moro","year":"2017","journal-title":"Drug Saf"},{"issue":"17","key":"10.1016\/j.vaccine.2017.09.049_b0060","first-page":"30252","article-title":"Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial","volume":"S1473\u20133099","author":"Steinhoff","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.049_b0065","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jpeds.2017.04.039","article-title":"Vaccine Safety Datalink. First trimester influenza vaccination and risks for major structural birth defects in offspring","volume":"187","author":"Kharbanda","year":"2017","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.vaccine.2017.09.049_b0070","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/aje\/kww043","article-title":"Risk of preterm or small-for-gestational-age birth after influenza vaccination during pregnancy: caveats when conducting retrospective observational studies","volume":"184","author":"Vazquez-Benitez","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"33","key":"10.1016\/j.vaccine.2017.09.049_b0075","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1016\/j.vaccine.2017.06.071","article-title":"Prenatal Tdap immunization and risk of maternal and newborn adverse events","volume":"35","author":"Layton","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.049_b0080","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1016\/j.vaccine.2017.06.069","article-title":"Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010\u201311 and 2011\u201312","volume":"35","author":"Donahue","year":"2017","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.vaccine.2017.09.049_b0085","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","article-title":"Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)","volume":"33","author":"Shimabukuro","year":"2015","journal-title":"Vaccine"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2017.09.049_b0090","doi-asserted-by":"crossref","first-page":"B108","DOI":"10.1016\/j.vaccine.2012.10.119","article-title":"Effective vaccine safety systems in all countries: a challenge for more equitable access to immunization","volume":"31","author":"Amarasinghe","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.049_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2015.06.073","article-title":"Enhancing vaccine safety capacity globally: a lifecycle perspective","author":"Chen","year":"2015","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17312975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17312975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T07:27:36Z","timestamp":1535354856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17312975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":19,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0264410X17312975"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.049","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Value of an in-depth analysis of unpublished data on the safety of influenza vaccines in pregnant women","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}